CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional paid-in capital	Retained earnings (deficit)	Total
Beginning Balances at Dec. 31, 2019	$ 7	$ 6,710	$ 3,348	$ 10,065
Beginning Balances (in shares) at Dec. 31, 2019	6,959,063
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options		19		19
Exercise of stock options (in shares)	10,000
Share issuance, net	$ 3	9,612		9,615
Share issuance, net (in shares)	3,296,725
Tax impact of equity transactions		(388)		(388)
Stock-based compensation		548		548
Equity component of convertible debt issuance		961		961
Fair value of finders' warrants		46		46
Settlement of performance share liability	$ 1	13,338		13,339
Settlement of performance share liability (in shares)	1,000,000
Settlement of payables		40		40
Settlement of payables (in shares)	10,000
Net loss			(15,036)	(15,036)
Ending Balance at Dec. 31, 2020	$ 11	30,886	(11,688)	19,209
Ending Balance (in shares) at Dec. 31, 2020	11,275,788
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options		19		19
Exercise of stock options (in shares)	3,000
Share issuance, net	$ 1	5,061		5,062
Share issuance, net (in shares)	1,150,594
Tax impact of equity transactions		(862)		(862)
Stock-based compensation		1,913		1,913
Equity component of convertible debt issuance		1,203		1,203
Settlement of performance share liability		2,293		2,293
Settlement of performance share liability (in shares)	43,968
Share issuance, acquisition related	$ 1	2,814		2,815
Share issuance, acquisition related (in shares)	432,117
Convertible debt converted into shares		60		60
Convertible debt converted into shares (in shares)	13,384
Other (in shares)	15
Net loss			(2,756)	(2,756)
Ending Balance at Dec. 31, 2021	$ 13	$ 43,387	$ (14,444)	$ 28,956
Ending Balance (in shares) at Dec. 31, 2021	12,918,866